Mikaël Le Clech, PhD, is a Business Developer at ChemBioFrance – CNRS. He leads several activities ranging from forging alliances with industrial partners to communication. Before joining ChemBioFrance, Mikaël held various positions in the field of biotechnology R&D, entrepreneurship and quality assurance. He was also head of the monoclonal antibody platform at the Max Planck Institute of Biochemistry, Munich. Mikaël holds a PhD from the University of Montpellier.